Alembic Ltd

Alembic Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Alembic Ltd

₹ 116 -3.15%
13 Jun - close price
alembiclimited.com BSE: 506235 NSE: ALEMBICLTD
About

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]

Key Points

Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): [1] [2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. [3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. [4]

Website BSE NSE
  • Market Cap ₹ 2,967 Cr.
  • Current Price ₹ 116
  • High / Low ₹ 169 / 85.5
  • Stock P/E 20.9
  • Book Value ₹ 33.2
  • Dividend Yield 2.08 %
  • ROCE 18.2 %
  • ROE 17.1 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 60.4%

Cons

  • Stock is trading at 3.48 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 12.5% over last 3 years.
  • Earnings include an other income of Rs.74.5 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Realty Realty Residential, Commercial Projects

Part of BSE SmallCap BSE Allcap BSE Consumer Discretionary

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
17 21 36 30 36 36 31 38 48 49 51 56 58
15 16 26 20 23 26 22 25 24 30 33 30 32
Operating Profit 3 5 10 10 13 10 10 13 23 19 18 26 26
OPM % 16% 23% 29% 33% 35% 28% 31% 35% 49% 40% 36% 46% 45%
4 1 59 2 -9 3 48 2 2 2 66 4 3
Interest 0 0 0 0 0 0 0 0 0 0 1 1 0
Depreciation 1 2 2 2 2 2 2 3 1 2 3 3 3
Profit before tax 6 4 68 11 2 11 56 13 24 19 81 27 26
Tax % 20% 10% 10% 1% -72% 13% 8% 10% 12% 9% 5% 4% 11%
5 4 61 10 4 9 51 11 21 17 77 26 23
EPS in Rs 0.18 0.14 2.37 0.41 0.17 0.37 2.00 0.44 0.81 0.66 2.98 1.00 0.89
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
154 144 134 147 125 124 74 72 76 123 152 214
126 134 128 140 114 106 70 62 63 85 96 125
Operating Profit 28 10 6 7 11 18 4 11 13 38 56 90
OPM % 18% 7% 5% 5% 9% 15% 5% 15% 17% 31% 37% 42%
18 21 25 25 37 29 93 10 89 54 55 75
Interest 4 1 0 0 0 0 0 0 0 0 1 2
Depreciation 8 6 6 5 4 3 3 4 4 6 7 10
Profit before tax 33 23 25 27 44 45 94 17 97 85 103 152
Tax % 12% -3% 2% -3% 5% 8% 0% 19% 12% 7% 10% 7%
30 24 25 27 42 41 94 13 86 79 93 142
EPS in Rs 1.11 0.90 0.93 1.03 1.56 1.60 3.64 0.52 3.34 3.09 3.62 5.53
Dividend Payout % 14% 17% 16% 19% 13% 12% 16% 38% 54% 71% 66% 43%
Compounded Sales Growth
10 Years: 4%
5 Years: 24%
3 Years: 41%
TTM: 41%
Compounded Profit Growth
10 Years: 19%
5 Years: 9%
3 Years: 20%
TTM: 54%
Stock Price CAGR
10 Years: 16%
5 Years: 12%
3 Years: 21%
1 Year: 11%
Return on Equity
10 Years: 10%
5 Years: 10%
3 Years: 12%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 53 53 53 53 53 51 51 51 51 51 51 51
Reserves 177 211 295 314 395 361 432 775 962 778 757 802
22 0 9 0 0 0 0 0 0 0 9 14
104 91 64 81 73 57 51 109 130 119 128 142
Total Liabilities 356 356 421 449 522 470 534 936 1,144 948 946 1,010
178 169 146 171 179 209 225 261 294 318 366 406
CWIP 2 2 0 0 0 0 3 6 0 0 1 0
Investments 21 35 150 189 276 205 197 581 726 503 411 414
155 149 124 89 67 55 109 88 124 127 168 190
Total Assets 356 356 421 449 522 470 534 936 1,144 948 946 1,010

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-10 22 10 52 24 22 5 -1 -22 35 25 81
18 5 -5 -47 -23 68 57 -35 23 11 23 -22
-8 -25 -5 -5 -3 -89 -6 -15 -6 -46 -48 -58
Net Cash Flow -0 2 -0 -0 -2 1 56 -52 -5 -0 0 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 66 122 76 54 74 40 44 66 72 67 42 47
Inventory Days 1,924 880 659 438 247 289 411 2,112 2,885 5,118 3,694 525
Days Payable 659 200 144 128 125 202 151 675 635 993 1,213 146
Cash Conversion Cycle 1,330 801 591 364 195 126 304 1,504 2,322 4,191 2,523 426
Working Capital Days 200 235 172 39 20 13 28 98 231 127 79 149
ROCE % 16% 9% 8% 8% 10% 10% 21% 2% 10% 10% 12% 18%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88%
1.08% 0.83% 0.82% 0.70% 0.72% 0.85% 0.89% 1.07% 1.42% 1.97% 1.78% 1.65%
4.29% 4.12% 3.94% 3.94% 3.93% 3.40% 0.04% 0.04% 0.04% 0.08% 0.06% 0.05%
23.75% 24.16% 24.34% 24.48% 24.46% 24.87% 28.17% 28.02% 27.66% 27.07% 27.27% 27.41%
No. of Shareholders 83,00683,61283,63082,33981,73282,94794,01299,13098,4781,02,2491,07,4231,06,732

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings